APA (7th ed.) Citation

Kater, A. P., Eichhorst, B. F., Owen, C. J., Jaeger, U., Chyla, B., Lefebure, M., . . . Seymour, J. F. (2024, August). Long‐term immune changes in patients with relapsed/refractory chronic lymphocytic leukemia following treatment with venetoclax plus rituximab. HemaSphere.

Chicago Style (17th ed.) Citation

Kater, Arnon P., et al. "Long‐term Immune Changes in Patients with Relapsed/refractory Chronic Lymphocytic Leukemia Following Treatment with Venetoclax Plus Rituximab." HemaSphere Aug. 2024.

MLA (9th ed.) Citation

Kater, Arnon P., et al. "Long‐term Immune Changes in Patients with Relapsed/refractory Chronic Lymphocytic Leukemia Following Treatment with Venetoclax Plus Rituximab." HemaSphere, Aug. 2024.